文献速递甲状腺疾病

F-18-Dopa PET/CT在甲状腺髓样癌复发定位中比全身MRI更敏感

F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.
PubMed 文献 · Thyroid · 2019-01-01

本研究比较了F-18-Dopa PET/CT、全身MRI、F-18-FDG PET/CT、全身CT、颈部超声和骨扫描在术后降钙素升高但未见明确病灶的甲状腺髓样癌患者中的病灶检出率。结论认为F-18-Dopa PET/CT对结构性病灶的敏感性优于其他影像手段。

要点

  • 术后降钙素升高的MTC患者,F-18-Dopa PET/CT检出率64%,全身MRI仅40%。
  • F-18-Dopa PET/CT在患者水平优于F-18-FDG PET/CT和全身CT。
  • 对于生化复发但传统影像阴性的MTC,可优先考虑F-18-Dopa PET/CT。

核心结论

  • 在降钙素升高且无已知远处转移的MTC患者中,F-18-Dopa PET/CT检测结构性疾病的敏感性高于包括全身MRI在内的其他影像 modality。

研究设计与样本

  • 比较各影像独立判读与参考评估(病理或两种影像一致或随访确认)的检出率,进行患者、器官和病灶水平分析。

主要发现

  • 参考评估在24例(64%)患者中定位疾病,共74个病灶(甲状腺床8、颈部淋巴结15、纵隔淋巴结6、肺1、肝2、骨3、其他1)。
  • 患者水平检出率:F-18-Dopa PET/CT(早期采集)64%(CI 0.48-0.80),F-18-FDG PET/CT 40%(CI 0.24-0.56),全身MRI 40%(CI 0.24-0.56),全身CT 48%(CI 0.31-0.66)。

临床怎么用

  • 对于术后降钙素升高但常规影像未定位的MTC患者,F-18-Dopa PET/CT可作为优先的功能影像检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Elevated postoperative serum calcitonin (Ctn) level indicates persistent/recurrent disease in patients with medullary thyroid carcinoma (MTC). Its location is a challenge. The aim of our study was to compare the disease detection rates of F-18-Dopa (fluoro dihydroxyphenylalanine) positron emission tomography (PET)/computed tomography (CT), whole-body (WB) magnetic resonance imaging (MRI), F-18-FDG (fluorodeoxyglucose) PET/CT, WB CT scanning, neck ultrasonography, and bone scintigraphy in MTC patients with increased Ctn levels and unknown localization of the source. Methods: We compared the independent reading of each imaging procedure with a reference assessment for structural disease defined by pathology or concordance between two imagings or with subsequent follow-up. The detection rate of each imaging modality was determined in per patient, per organ, and per lesion analysis. Results: Thirty-six consecutive patients (21 females, mean age: 57 years, sporadic MTC in 26 cases, median serum Ctn level: 760 pg/mL; range: 21-10,121) were analyzed. The reference assessment localized disease in 24 (64%) patients with 74 lesions detected in the thyroid bed (8), in neck lymph nodes (15), mediastinal lymph nodes (6), lungs (1), liver (2), bones (3), and other site (1). At the patient level, the detection rates were 64% (CI 0.48-0.80) for F-18-Dopa PET/CT with early acquisitions, 40% (CI 0.24-0.56) for F-18-FDG PET/CT, 40% (CI 0.24-0.56) for WB MRI, and 48% (CI 0.31-0.66) for WB CT scan. Conclusions: In MTC patients with increased Ctn and no known distant metastases, F-18-Dopa PET/CT is more sensitive to detect structural disease than any other imaging modality, including WB MRI.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Terroir M, Caramella C, Borget I, et al. F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients. Thyroid. 2019. PMID: 31530235. doi:10.1089/thy.2018.0351

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。